Cyanogen bromide is the inorganic compound with the formula (CN)Br or BrCN. It is a colorless solid that is widely used to modify biopolymers, fragment proteins and peptides (cuts the C-terminus of methionine), and synthesize other compounds. The compound is classified as a pseudohalogen.
|Preferred IUPAC name
3D model (JSmol)
CompTox Dashboard (EPA)
|Molar mass||105.921 g mol−1|
|Density||2.015 g mL−1|
|Melting point||50 to 53 °C (122 to 127 °F; 323 to 326 K)|
|Boiling point||61 to 62 °C (142 to 144 °F; 334 to 335 K)|
|Vapor pressure||16.2 kPa|
Std enthalpy of
|136.1–144.7 kJ mol−1|
|GHS Signal word||Danger|
|H300, H310, H314, H330, H410|
|P260, P273, P280, P284, P302+350|
|NFPA 704 (fire diamond)|
|NIOSH (US health exposure limits):|
|5 mg m−3|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Synthesis, basic properties, and structureEdit
The carbon atom in cyanogen bromide is bonded to bromine by a single bond and to nitrogen by a triple bond (i.e. Br–C≡N). The compound is linear and polar, but it does not spontaneously ionize in water. It dissolves in both water and polar organic solvents.
- 2 NaCN + Br2 → (CN)2 + 2 NaBr
- (CN)2 + Br2 → 2 (CN)Br
When refrigerated the material has an extended shelflife. Like some other cyanogen compounds, cyanogen bromide undergoes an exothermic trimerisation to cyanuric bromide ((BrCN)3). This reaction is catalyzed by traces of bromine, metal salts, acids and bases. For this reason, experimentalists avoid brownish samples.
- (CN)Br + H2O → HCN + HOBr
Cyanogen bromide is often used to immobilize proteins by coupling them to reagents such as agarose for affinity chromatography. Because of its simplicity and mild pH conditions, cyanogen bromide activation is the most common method for preparing affinity gels. Cyanogen bromide is also often used because it reacts with the hydroxyl groups on agarose to form cyanate esters and imidocarbonates. These groups are reacted with primary amines in order to couple the protein onto the agarose matrix, as shown in the figure. Because cyanate esters are more reactive than are cyclic imidocarbonates, the amine will react mostly with the ester, yielding isourea derivatives, and partially with the less reactive imidocarbonate, yielding substituted imidocarbonates.
The disadvantages of this approach include the toxicity of cyanogen bromide and its sensitivity to oxidation. Also, cyanogen bromide activation involves the attachment of a ligand to agarose by an isourea bond, which is positively charged at neutral pH and thus unstable. Consequently, isourea derivatives may act as weak anion exchangers.[dead link]
The electron density in cyanogen bromide is shifted away from the carbon atom, making it unusually electrophilic, and towards the more electronegative bromine and nitrogen. This leaves the carbon particularly vulnerable to attack by a nucleophile, and the cleavage reaction begins with a nucleophilic acyl substitution reaction in which bromine is ultimately replaced by the sulfur in methionine. This attack is followed by the formation of a five-membered ring as opposed to a six-membered ring, which would entail the formation of a double bond in the ring between nitrogen and carbon. This double bond would result in a rigid ring conformation, thereby destabilizing the molecule. Thus, the five-membered ring is formed so that the double bond is outside the ring, as shown in the figure.
Although the nucleophilic sulfur in methionine is responsible for attacking BrCN, the sulfur in cysteine does not behave similarly. If the sulfur in cysteine attacked cyanogen bromide, the bromide ion would deprotonate the cyanide adduct, leaving the sulfur uncharged and the beta carbon of the cysteine not electrophilic. The strongest electrophile would then be the cyanide nitrogen, which, if attacked by water, would yield cyanic acid and the original cysteine.
Cleaving proteins with BrCN requires using a buffer such as 0.1M HCl (hydrochloric acid) or 70% (formic acid). These are the most common buffers for cleavage. An advantage to HCl is that formic acid causes the formation of formyl esters, which complicates protein characterization. However, formic is still often used because it dissolves most proteins. Also, the oxidation of methionine to methionine sulfoxide, which is inert to BrCN attack, occurs more readily in HCl than in formic acid, possibly because formic acid is a reducing acid. Alternative buffers for cleavage include guanidine or urea in HCl because of their ability to unfold proteins, thereby making methionine more accessible to BrCN.
Note that water is required for normal peptide bond cleavage of the iminolactone intermediate. In formic acid, cleavage of Met-Ser and Met-Thr bonds is enhanced with increased water concentration because these conditions favor the addition of water across the imine rather than reaction of the side chain hydroxyl with the imine. Lowered pH tends to increase cleavage rates by inhibiting methionine side chain oxidation.
When methionine is followed by serine or threonine, side reactions can occur that destroy the methionine without peptide bond cleavage. Normally, once the iminolactone is formed (refer to figure), water and acid can react with the imine to cleave the peptide bond, forming a homoserine lactone and new C-terminal peptide. However, if the adjacent amino acid to methionine has a hydroxyl or sulfhydryl group, this group can react with the imine to form a homoserine without peptide bond cleavage. These two cases are shown in the figure.
Cyanogen bromide is a common reagent in organic synthesis. As stated earlier, the reagent is prone to attack by nucleophiles such as amines and alcohols because of the electrophilic carbon. In the synthesis of cyanamides and dicyanamides, primary and secondary amines react with BrCN to yield mono- and dialkylcyanamides, which can further react with amines and hydroxylamine to yield guanidines and hydroxyguanidines. In the von Braun reaction, tertiary amines react with BrCN to yield disubstituted cyanamides and an alkyl bromide. Cyanogen bromide can be used to prepare aryl nitriles, nitriles, anhydrides, and cyanates. It can also serve as a cleaving agent. Cyanogen bromide is used in the synthesis of 4-methylaminorex ("ice") and viroxime.
Toxicity, storage, and deactivationEdit
Cyanogen bromide can be stored under dry conditions at 2 to 8 °C for extended periods.
Cyanogen bromide is volatile, and readily absorbed through the skin or gastrointestinal tract. Therefore, toxic exposure may occur by inhalation, physical contact, or ingestion. It is acutely toxic, causing a variety of nonspecific symptoms. Exposure to even small amounts may cause convulsions or death. LD50 orally in rats is reported as 25–50 mg/kg.
The recommended method to deactivate cyanogen bromide is with bleach. The aqueous alkali hydroxide instantly hydrolyzes (CN)Br to alkali cyanide and bromide. The cyanide can then be oxidized by sodium or calcium hypochlorite to the less toxic cyanate ion. Note that deactivation is extremely exothermic and may be explosive.
- The Merck Index (10th ed.). Rahway, NJ: Merck & Co. 1983. p. 385.
- "Campilit, CAS Number: 506-68-3".
- "Cyanogen Bromide – Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 26 March 2005. Identification. Retrieved 4 June 2012.
- Morris, Joel; Kovács, Lajos; Ohe, Kouichi (2015). "Cyanogen Bromide". Encyclopedia of Reagents for Organic Synthesis. pp. 1–8. doi:10.1002/047084289X.rc269.pub3. ISBN 9780470842898.
- Joel Morris; Lajos Kovács (2008). "Cyanogen Bromide". Encyclopedia of Reagents for Organic Synthesis. doi:10.1002/047084289X.rc269.pub2. ISBN 978-0471936237.
- Hermanson, G. T.; Mallia, A. K.; Smith, P. K. (1992). Immobilized Affinity Ligand Techniques. Academic Press. ISBN 978-0-12-342330-6.
- "Cyanogen Bromide Activated Matrices" (PDF). Sigma.[dead link]
- Schroeder, W. A.; Shelton, J. B.; Shelton, J. R. (1969). "An Examination of Conditions for the Cleavage of Polypeptide Chains with Cyanogen Bromide". Archives of Biochemistry and Biophysics. 130 (1): 551–556. doi:10.1016/0003-9861(69)90069-1. PMID 5778667.
- Kaiser, R.; Metzka, L. (1999). "Enhancement of Cyanogen Bromide Cleavage Yields for Methionyl-Serine and Methionyl-Threonine Peptide Bonds". Analytical Biochemistry. 266 (1): 1–8. doi:10.1006/abio.1998.2945. PMID 9887207.
- Kumar, V. (2005). "Cyanogen Bromide (CNBr)" (PDF). Synlett. 2005 (10): 1638–1639. doi:10.1055/s-2005-869872. Art ID: V12705ST.
- "Cyanogen Bromide HSDB 708". HSDB. NIH / NLM. 2009-04-07.
- Lunn, G.; Sansone, E. B. (1985). "Destruction of Cyanogen Bromide and Inorganic Cyanides". Analytical Biochemistry. 147 (1): 245–250. doi:10.1016/0003-2697(85)90034-X. PMID 4025821.
- Gross, E.; Witkop, B. (1962). "Nonenzymatic Cleavage of Peptide Bonds: The Methionine Residues in Bovine Pancreatic Ribonuclease" (PDF). Journal of Biological Chemistry. 237 (6): 1856–1860. PMID 13902203.
- Inglis, A. S.; Edman, P. (1970). "Mechanism of Cyanogen Bromide Reaction with Methionine in Peptides and Proteins". Analytical Biochemistry. 37 (1): 73–80. doi:10.1016/0003-2697(70)90259-9. PMID 5506566.